S. 1818
Introduced in Senate · May 28, 2025May 20, 2025
Mr. Sanders (for himself, Mr. Blumenthal, Mr. Booker, Mr. Merkley, Mr. Murphy, Mr. Welch, and Ms. Warren) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions
A BILL
To significantly lower prescription drug prices for patients in the United States by ending government-granted monopolies for manufacturers who charge drug prices that are higher than the median prices at which the drugs are available in other countries.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. Short title.
This Act may be cited as the “Prescription Drug Price Relief Act of 2025”.